Light, Sleep and Circadian Rhythms in Older Adults With Alzheimer’s Disease and Related Dementias
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease and related dementias (ADRD) can cause sleep and behavioral problems that are problematic for ADRD patients and their family caregivers. Light therapy has shown promise as a nonpharmacological treatment, and preliminary studies demonstrate that timed light exposure can consolidate and improve nighttime sleep efficiency, increase daytime wakefulness and reduce evening agitation without the adverse effects of pharmacological solutions. Compliance with light treatment and the accurate measurement of light exposures during treatment, however, have presented barriers for the adoption of light therapy for ADRD. Recent research showing that the circadian system is maximally sensitive to short-wavelength light opens the way for the potential application of lower, more-targeted light intensities to maximize compliance and individualize light dose/timing in therapeutic settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor
Brainard, G. C., Hanifin, J. P., Greeson, J. M., Byrne, B., Glickman, G., Gerner, E., & Rollag, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06405.2001 · Cited by 1,930 · cited 1×
“Humans are “blue sky detectors;” the peak sensitivity for acute melatonin suppression and phase shifting of DLMO is close to 460 nanometers (nm) [11-13].”
Light Suppresses Melatonin Secretion in Humans
Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A., & Markey, S. P. (1980) · Science · doi:10.1126/science.7434030 · Cited by 1,913
Preventing Falls in Elderly Persons
Tinetti, M. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp020719 · Cited by 1,660
Thapan, K., Arendt, J., & Skene, D. J. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.t01-1-00261.x · Cited by 1,320 · cited 1×
“Humans are “blue sky detectors;” the peak sensitivity for acute melatonin suppression and phase shifting of DLMO is close to 460 nanometers (nm) [11-13].”
Hattar, S., Lucas, R. J., Mrosovsky, N., Thompson, S., Douglas, R. H., Hankins, M. W., Lem, J., Biel, M., Hofmann, F., Foster, R. G., et al. (2003) · Nature · doi:10.1038/nature01761 · Cited by 1,245 · cited 1×
“Rods, cones and the intrinsically photosensitive retinal ganglion cells (ipRGCs) participate in circadian phototransduction, which is how the retina converts light signals into neural signals for the biological clock [7].”
Zeitzer, J. M., Dijk, D., Kronauer, R. E., Brown, E. N., & Czeisler, C. A. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00695.x · Cited by 1,175 · cited 2×
“It is now known that lower levels of light, less than those originally demonstrated in the 1980s, can acutely decrease melatonin concentration and affect the timing of melatonin onset and offset; however, light levels needed to affect melatonin are still higher than those needed to affect vision [8,9].”
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“A meta-analysis of sedative/hypnotic medications for older people with insomnia concluded that the benefits of sleep medication may not justify the increased risk [50].”
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095 · cited 1×
“Medications, often prescribed for sleep problems, have low effectiveness [42,43] and are associated with adverse effects, such as worsening confusion, falls, and hip fractures [44-49].”
A Phase Response Curve to Single Bright Light Pulses in Human Subjects
Khalsa, S. B. S., Jewett, M. E., Cajochen, C., & Czeisler, C. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.040477 · Cited by 1,040 · cited 2×
“bedtimes, and is used as a marker of the circadian clock [6].”
Metabolic consequences of sleep and sleep loss
Van Cauter, E., Spiegel, K., Tasali, E., & Leproult, R. (2008) · Sleep Medicine · doi:10.1016/s1389-9457(08)70013-3 · Cited by 812
Riemersma-van der Lek, R. F. (2008) · JAMA · doi:10.1001/jama.299.22.2642 · Cited by 803 · cited 1×
“[69] conducted a long-term, double-blind, placebo-controlled study with 189 elderly patients with dementia living in nursing homes.”
Circadian Rhythm Sleep Disorders: Part I, Basic Principles, Shift Work and Jet Lag Disorders
Sack, R. L., Auckley, D., Auger, R. R., Carskadon, M. A., Wright, K. P., Vitiello, M. V., & Zhdanova, I. V. (2007) · Sleep · doi:10.1093/sleep/30.11.1460 · Cited by 650
Leproult, R., Holmbäck, U., & Van Cauter, E. (2014) · Diabetes · doi:10.2337/db13-1546 · Cited by 607 · cited 1×
“of light of the right spectrum, for a sufficient amount of time, and with the right timing, the biological clock becomes desynchronized with the solar day and humans may experience decrements in physiological functions, neurobehavioral performance and sleep [1-4].”
The effects of prior light history on the suppression of melatonin by light in humans
Hébert, M., Martin, S. K., Lee, C., & Eastman, C. I. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.01885.x · Cited by 413 · cited 4×
“Photic history, or the amount of light received during the previous day determines the effectiveness of light on acute melatonin suppression and on the phase shifting of the timing of DLMO [14-16].”
InfluentialAncoli-Israel, S., Gehrman, P., Martin, J. L., Shochat, T., Marler, M., Corey-Bloom, J., & Levi, L. (2003) · Behavioral Sleep Medicine · doi:10.1207/s15402010bsm0101_4 · Cited by 347 · cited 1×
“[60] administered light (2500 lux at the cornea) for 2 h in the morning or the evening for 10 consecutive days and found both groups of ADRD patients (those who received morning and those who received evening light) exhibited more consolidated sleep at night, as measured by average length of maximum nocturnal sleep bo…”
Circadian photoreception: ageing and the eye's important role in systemic health
Turner, P. L., & Mainster, M. A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.141747 · Cited by 315 · cited 1×
“Additionally, when discussing the effects of light on the aging population, it is important to keep in mind that the first stage of phototransduction, when light signals are converted into neural signals, is negatively affected in this population: older adults have reduced optical transmission at short wavelengths [23…”
Illumination levels in nursing home patients: effects on sleep and activity rhythms
Shochat, T., Martin, J., Marler, M., & Ancoli‐Israel, S. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00221.x · Cited by 262 · cited 1×
“Moreover, older adults, especially those with ADRD typically lead a more sedentary indoor lifestyle, with less access to bright light during the day, potentially increasing the risk for circadian disruption [27-29].”
Allain, H., Bentu??-Ferrer, D., Polard, E., Akwa, Y., & Patat, A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522090-00004 · Cited by 214 · cited 1×
“Medications, often prescribed for sleep problems, have low effectiveness [42,43] and are associated with adverse effects, such as worsening confusion, falls, and hip fractures [44-49].”
Figueiro, M., Plitnick, B., Lok, A., Jones, G., Higgins, P., Hornick, T., & Rea, M. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s68557 · Cited by 211
Self-citationForbes, D., Blake, C. M., Thiessen, E. J., Peacock, S., & Hawranik, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003946.pub4 · Cited by 194 · cited 2×
“in their latest Cochrane review [77] analyzed studies that used a variety of light therapy approaches.”
Figueiro, M., Hamner, R., Bierman, A., & Rea, M. (2013) · Lighting Research & Technology · doi:10.1177/1477153512450453 · Cited by 179 · cited 6×
“The Daysimeter is calibrated in terms of orthodox photopic illuminance (lux) and of circadian illuminance (CLA).”
InfluentialSelf-citationBright light therapy for agitation in dementia: a randomized controlled trial
Burns, A., Allen, H., Tomenson, B., Duignan, D., & Byrne, J. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008886 · Cited by 171 · cited 1×
“[74] exposed dementia patients to either 10,000 lux at the cornea (treatment condition) or 100 lux at the cornea (control) of light for 4 consecutive weeks and”
Yamadera, H., Ito, T., Suzuki, H., Asayama, K., Ito, R., & Endo, S. (2000) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2000.00711.x · Cited by 148 · cited 1×
“[62] found that 4 weeks of morning bright light (3000 lux at the cornea) administered to 27 ADRD patients resulted in improved mental status scores, decreased percentage of daytime naps/naptime, increased percentage of nighttime sleep time, and decreased percentage of nighttime awakenings.”
Light therapy and Alzheimer’s disease and related dementia: Past, present, and future
Hanford, N., & Figueiro, M. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2012-121645 · Cited by 136
Self-citationChang, A.-M., Scheer, F. A. J. L., Czeisler, C. A., & Aeschbach, D. (2013) · Sleep · doi:10.5665/sleep.2894 · Cited by 131
Cited by
Association between circadian rhythms and neurodegenerative diseases
Leng, Y., Musiek, E. S., Hu, K., Cappuccio, F. P., & Yaffe, K. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30461-7 · Cited by 654
Time-restricted eating for the prevention and management of metabolic diseases
Manoogian, E. N. C., Chow, L. S., Taub, P. R., Laferrère, B., & Panda, S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab027 · Cited by 344
“Controlled animal and human studies have shown correcting the CRD by controlled lighting or optimal sleep can prevent or lessen the respective disease risks (7-10).”
BackgroundDiagnosing and Treating Depression in Patients with Alzheimer’s Disease
Burke, A. D., Goldfarb, D., Bollam, P., & Khokher, S. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00148-5 · Cited by 115
Application of light therapy in older adults with cognitive impairment: a systematic review
Cibeira, N., Maseda, A., Lorenzo-López, L., Rodríguez-Villamil, J. L., López-López, R., & Millán-Calenti, J. C. (2020) · Geriatric Nursing · doi:10.1016/j.gerinurse.2020.07.005 · Cited by 25
Metadata
- Authors
- Figueiro, M. G.
- Venue
- Neurodegenerative Disease Management
- Publisher
- Informa UK Limited
- Published
- 2017-04
- Volume
- 7
- Issue
- 2
- Pages
- 119-145
- ISSN
- 1758-2024 (ISSN-L)
- 1758-2032
- OpenAlex
- W2620482803
- Cited by
- 66
- References
- 25
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.